loadpatents
Patent applications and USPTO patent grants for COOPER; Nicola.The latest application filed is for "use of amisulpride as an anti-emetic".
Patent | Date |
---|---|
Use Of Amisulpride As An Anti-emetic App 20220296570 - GILBERT; Julian Clive ;   et al. | 2022-09-22 |
Method For The Treatment Of A Relapsing-remitting Condition App 20220281929 - Lightfoot; Andrew ;   et al. | 2022-09-08 |
Mycobacteria tuberculosis chaperonin 60.1 peptides and uses thereof Grant 11,098,090 - Lightfoot , et al. August 24, 2 | 2021-08-24 |
Use Of Amisulpride As An Anti-emetic App 20210228543 - GILBERT; Julian Clive ;   et al. | 2021-07-29 |
Method for the Treatment of a Relapsing-Remitting Condition App 20210230233 - Lightfoot; Andrew ;   et al. | 2021-07-29 |
Use Of Amisulpride As An Anti-emetic App 20200093792 - GILBERT; Julian Clive ;   et al. | 2020-03-26 |
Mycobacteria Tuberculosis Chaperonin 60.1 Peptides and Uses Thereof App 20200071365 - Lightfoot; Andrew ;   et al. | 2020-03-05 |
Use of amisulpride as an anti-emetic Grant 10,525,033 - Gilbert , et al. J | 2020-01-07 |
Use Of Amisulpride As An Anti-emetic App 20180353473 - GILBERT; Julian Clive ;   et al. | 2018-12-13 |
Use of bethanechol for treatment of xerostomia Grant 10,137,084 - Cooper , et al. November 27, 2 | 2018-11-27 |
Use of amisulpride as an anti-emetic Grant 10,085,970 - Gilbert , et al. October 2, 2 | 2018-10-02 |
Use Of Amisulpride As An Anti-emetic App 20180042896 - Gilbert; Julian Clive ;   et al. | 2018-02-15 |
Use of amisulpride as an anti-emetic Grant 9,889,118 - Gilbert , et al. February 13, 2 | 2018-02-13 |
Use Of Amisulpride As An Anti-emetic App 20170087128 - Gilbert; Julian Clive ;   et al. | 2017-03-30 |
Use of amisulpride as an anti-emetic Grant 9,545,426 - Gilbert , et al. January 17, 2 | 2017-01-17 |
Use Of Bethanechol For Treatment Of Xerostomia App 20160287512 - Cooper; Nicola ;   et al. | 2016-10-06 |
Use Of Bethanechol For Treatment Of Xerostomia App 20150366794 - Cooper; Nicola ;   et al. | 2015-12-24 |
Use of Amisulpride as an Anti-Emetic App 20150335616 - Gilbert; Julian Clive ;   et al. | 2015-11-26 |
Use of bethanechol for treatment of xerostomia Grant 9,149,454 - Cooper , et al. October 6, 2 | 2015-10-06 |
Use of amisulpride as an anti-emetic Grant 9,119,836 - Gilbert , et al. September 1, 2 | 2015-09-01 |
Use of Amisulpride as an Anti-Emetic App 20140147517 - Gilbert; Julian Clive ;   et al. | 2014-05-29 |
Use of amisulpride as an anti-emetic Grant 8,686,019 - Gilbert , et al. April 1, 2 | 2014-04-01 |
Use of Amisulpride as an Anti-Emetic App 20130022688 - GILBERT; Julian Clive ;   et al. | 2013-01-24 |
Use of Amisulpride as an Anti-Emetic App 20130022689 - Gilbert; Julian Clive ;   et al. | 2013-01-24 |
Use of Bethaneciol for Treatment of Xerostomia App 20120232137 - Cooper; Nicola ;   et al. | 2012-09-13 |
Container Grant D499,648 - Lewis , et al. December 14, 2 | 2004-12-14 |
Use of anthroquinones in the treatment of kidney disease App 20040248864 - Bannister, Robin Mark ;   et al. | 2004-12-09 |
Container Grant D494,472 - Lewis , et al. August 17, 2 | 2004-08-17 |
Use of anti-muscarinic agents and calcium channel blockers in combination App 20040028734 - Bannister, Robin Mark ;   et al. | 2004-02-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.